CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-15). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2638 · Search date 2026-08-15 · Methodology v0.7

Preoperative chlorhexidine whole-body washing,
does it really help with Prevention of surgical-site infection?

30-Second Summary
D
Evidence Grade D · 30 · Safety caution
Skin antisepsis is real, but fewer surgical-site infections were not reproduced and a modest benefit remains possible
Chlorhexidine can cause contact dermatitis and, rarely, severe allergy. Avoid mucosal, eye, and ear exposure and follow the surgical facility's protocol.
What the
research shows
The grade is D with 30 points. Four trials comparing chlorhexidine with an identical nonantimicrobial cleanser included 7,791 participants and gave RR 0.91 (95% CI 0.80 to 1.04). Independent trials did not reproduce fewer infections, but the interval still permits a reduction as large as 20%, so prevention has not been fully excluded.
What the
ads claim
Lower skin microbial counts are not the same endpoint as fewer surgical-site infections. Patients should not alter a surgical team's protocol or ignore chlorhexidine allergy.
*

Useful facts when choosing a product

  • Chlorhexidine reduces skin microorganisms, whereas this verdict concerns clinical surgical-site infection.
  • Rotter reported 37 of 1,413 versus 33 of 1,400 infections after two washes.
  • The seven-trial Cochrane review summarizes included trials and is not an additional replication.
Gap Measurement · Verdict 2638 · D 30
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Webster and Osborne's 2015 Cochrane review included seven randomized trials and 10,157 participants. Four trials of 4% chlorhexidine versus placebo gave RR 0.91 (0.80-1.04), with no measured heterogeneity. The two stricter large trials by Byrne and Rotter included 6,302 participants and gave RR 0.95 (0.82-1.10), again with no measured heterogeneity. Rotter randomized 2,953 and analyzed 2,813, 1,413 versus 1,400, after 140 exclusions; infections were 37 versus 33, RR 1.11 (0.70-1.77). Coded identical containers masked patients and investigators and computer numbers with mixed packs implemented assignment, but postrandomization exclusions and no registration remain. ICI supplied bathing materials; separate trial funding was not identified. The review disclosed university and UK NIHR support.

02

Why this is classified as D (30)

Several independent placebo-controlled trials did not reproduce fewer infections, but their precision and clinical boundaries did not exclude meaningful benefit, giving D with 30 points.

Counterpoint. These data cannot negate every distinct operation, concentration, or adherence protocol.

Rejudgment record. Cross-check applied — Verified included trials, pooled estimates, heterogeneity, and bias in the Cochrane text and cross-checked assignment, analysis counts, masking, and supplied materials in Rotter

Scoring profile behind this grade
EndpointHHard endpoint - actual events such as death
ReplicationRXRepeatedly refuted in the same indication
IndependenceI1Mixed funding sources
Effect sizeE0Null
PrecisionC0The confidence interval leaves room for benefit

The scoring table and the verdict agree (D).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Prevention of surgical-site infectionDResults were repeatedly null but still allowed up to a 20% reduction.
Reduction in skin microorganisms?This is an established antiseptic action, not the clinical endpoint graded here.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Webster J, Osborne S. Cochrane review 2015Systematic review of randomized trials7,791Internal QUT and Griffith support and external NIHR support; no conflicts declaredSurgical-site infectionChlorhexidine versus placebo RR 0.91 (0.80-1.04), with measured heterogeneity of 0%Pivotal pooled evidence
Study 2Multinational double-masked placebo-controlled randomized trial1,400ICI supplied bathing materials; separate funding not reportedPostoperative wound infection37/1,413 versus 33/1,400, RR 1.11 (0.70-1.77)Large direct placebo-controlled trial
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-15).

Webster J, Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev. 2015;(2):CD004985. PMID: 25927093. PMCID: PMC10120916. DOI: 10.1002/14651858.CD004985.pub5.
checked
Rotter ML, Larsen SO, Cooke EM, et al. A comparison of the effects of preoperative whole-body bathing with detergent alone and with detergent containing chlorhexidine gluconate on the frequency of wound infections after clean surgery. J Hosp Infect. 1988;11(4):310-320. PMID: 2899582. DOI: 10.1016/0195-6701(88)90083-7.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-15 · Corrections: none

Cite this verdict

Preoperative chlorhexidine whole-body washing x surgical-site infection Evidence Grade D card
[Chamgap] Preoperative chlorhexidine whole-body washing x surgical-site infection — Evidence Grade D·30. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/immunity/preoperative-chlorhexidine-whole-body-washing-surgical-site-infection/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.